SCHEMBL9707524

SCHEMBL9707524

CC(C)Cn1c(=O)n(C)c(=O)c2c1nc(C1CCCCC1)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
AGTR1 P30556 2/20 0.40
AGTR2 P50052 2/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
PDE1C Q14123 1/20 0.40
MAPK1 P28482 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
POLB P06746 1/20 0.39
BLM P54132 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
PDE5A O76074 5/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707617 0.94 KMT2A (0.43) KMT2AAGTR1AGTR2MAPK1TP53
SCHEMBL9708682 0.94 KMT2A (0.41) KMT2AAGTR1AGTR2MAPK1POLB
SCHEMBL9708295 0.92 ADORA3 (0.45) KMT2AAGTR1AGTR2PDE5A
SCHEMBL9707670 0.92 PDE5A (0.43) KMT2AAGTR1AGTR2PDE5A
SCHEMBL9708549 0.92 KMT2A (0.45) KMT2AAGTR1AGTR2MAPK1TP53
SCHEMBL9707375 0.91 ADORA3 (0.44) KMT2AAGTR1AGTR2PDE5A
SCHEMBL9708269 0.91 ADORA2A (0.46) KMT2AAGTR1AGTR2MAPK1TP53
SCHEMBL9708520 0.91 TSHR (0.48) KMT2AAGTR1AGTR2MAPK1TP53
SCHEMBL9708163 0.91 KMT2A (0.40) KMT2AAGTR1AGTR2MAPK1POLB
SCHEMBL9707688 0.91 PDE5A (0.42) KMT2AAGTR1AGTR2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO claimed
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed